Exactly. Too many here operate as if all the IFs are already resolved to CYDYs benefit. CYDY may be worth a lot more per share someyime in the future (measured in years), but not tomorrow. And my buyout offer speculation after FDA approval for COVID-19 was already inflated. Volume discounting will kick in. And if CYDY wants to be a player on the international market, they will have to pay by the rules of other nations' universal health care systems. They won't be able to charge outrageous premiums outside of the US.